Cholesterol, an essential fat for cellular function, is now becoming a major concern in India’s fight against non-communicable diseases. Studies show that the mean cholesterol levels in India are rising steadily, contributing to heart diseases. Heart diseases account for nearly 28% of all deaths in India, which in comparison surpasses those caused by diabetes and high blood pressure.
Among the components of cholesterol, LDL cholesterol (LDLC), also known as ‘bad cholesterol’ stands out as a critical concern. It is often termed a ‘silent killer’ because its increasing levels in the blood do not exhibit any noticeable symptoms. It starts clogging the arteries and builds an obstruction to the blood flow, causing damage to the arteries and leading to heart attacks and strokes.
High LDLC levels are more notable in the northern and southern states. A recent survey revealed that 31% of Indians have elevated cholesterol levels, with certain regions, including Hyderabad, reporting prevalence rates as high as 27.4%. Young adults can encounter heart-related conditions as early as the age of 18. Therefore, all individuals should have their lipid profile evaluated by then. Regular tests, followed by personalized treatment plans, can help reduce long-term risks. Sedentary lifestyles, stressful environments, and the growing consumption of processed and fatty foods largely fuel the escalating burden of high LDLC across the country.
Dr. PLN Kaparathi, Cath Lab Director, Senior Consultant, Cardiologist, Care Hospital Banjara Hills, Hyderabad says “Addressing cardiovascular challenges requires educating patients, improving healthcare access, and focusing on medication adherence. There are safe and effective cholesterol-lowering therapies available. The patients that come with LDLC complaints are generally from the age of 30 to 55. Underdiagnosis is a primary factor behind growing cholesterol levels in India. Regular lipid profile checks should be a part of routine health check-ups and can aid in the early detection and effective treatment and management of high LDLC levels.”
Managing cholesterol involves achieving optimal LDLC levels based on factors such as age, gender, family history etc. Treatment strategies must also account for comorbid conditions and overall cardiovascular risk. For instance, patients with diabetes and atherosclerotic cardiovascular disease (ASCVD) should aim for LDLC levels below 55 mg/dL, whereas those with diabetes and additional risk factors are advised to target levels below 70 mg/dL.
Although lipid profile tests are widely available, their utilization is limited due to a lack of awareness and misconceptions. Even when treatment starts, patients frequently discontinue treatment once they feel better, causing LDLC levels to rise again without obvious symptoms. Combining healthy eating, regular exercising and medication is an effective strategy to maintain the target LDLC levels. For those with high LDLC, while lifestyle modifications are helpful, they cannot replace medicines to stay on track of target LDLC levels.
India’s battle against high cholesterol needs a collective effort. Regular screenings, timely treatments, and promoting healthy habits can help curb this growing epidemic, ensuring longer and healthier lives for everyone.